Granules India Gagilapur unit gets USFDA warning letter, new product approval to see impact

Share it

Shares of Granules India Ltd ended at ₹502.00, down by ₹11.75, or 2.29% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *